Different from some current data-driven models30, the presented model recapitulated many clinically or experimentally observed important phenotypes of SQT1 as well as the drug effects at multiple levels, thus facilitating our understanding of the mechanism underlying SQTS. The gene discussed is KCNH2; the disease is Familial short QT syndrome.